Patents by Inventor Duncan Robert Hannah

Duncan Robert Hannah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • H4 ANTAGONIST COMPOUNDS
    Publication number: 20230167094
    Abstract: The disclosure herein relates to azetidinylpyrimidin-2-amine derivatives, their use as Histamine H4 receptor antagonists and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with H4 receptors.
    Type: Application
    Filed: April 22, 2021
    Publication date: June 1, 2023
    Applicant: Heptares Therapeutics Limited
    Inventors: Miles Stuart CONGREVE, Charlotte FIELDHOUSE, Nigel Alan SWAIN, Mark PICKWORTH, Duncan Robert HANNAH
  • Hydroxamic and carboxylic acid derivatives
    Patent number: 6933306
    Abstract: Pharmacologically active compounds are provided as well as pharmaceutical compositions and methods for treating cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration in a mammal.
    Type: Grant
    Filed: October 25, 2002
    Date of Patent: August 23, 2005
    Assignee: Darwin Discovery Ltd.
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Robert John Watson, John Fraser Keily, Andrew Douglas Baxter
  • Hydroxamic acid derivatives
    Publication number: 20040266764
    Abstract: The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.
    Type: Application
    Filed: July 29, 2004
    Publication date: December 30, 2004
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Andrew Sharpe, Andrew Douglas Baxter
  • Hydroxamic acid derivatives
    Patent number: 6809100
    Abstract: The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: October 26, 2004
    Assignee: Darwin Discovery Ltd.
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Andrew Sharpe, Andrew Douglas Baxter
  • Hydroxamic acid derivatives
    Patent number: 6787536
    Abstract: The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: September 7, 2004
    Assignee: Darwin Discovery Limited
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Andrew Sharpe, Andrew Douglas Baxter
  • Hydroxamic acid derivatives
    Publication number: 20030216404
    Abstract: The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.
    Type: Application
    Filed: June 12, 2003
    Publication date: November 20, 2003
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Andrew Sharpe, Andrew Douglas Baxter
  • Quinolone derivatives
    Publication number: 20030105073
    Abstract: Quinolone derivatives of formula (1) are described: 1
    Type: Application
    Filed: October 22, 2002
    Publication date: June 5, 2003
    Inventors: Alan Findlay Haughan, Hazel Joan Dyke, George Martin Buckley, Natasha Davies, Duncan Robert Hannah, Marianna Dilani Richard, Andrew Sharpe, Sophie Caroline Williams
  • Hydroxamic and carboxylic acid derivatives
    Publication number: 20030092727
    Abstract: Pharmacologically active compounds are provided as well as pharmaceutical compositions and methods for treating cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration in a mammal.
    Type: Application
    Filed: October 25, 2002
    Publication date: May 15, 2003
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Robert John Watson, John Fraser Keily, Andrew Douglas Baxter
  • Hydroxamic and carboxylic acid derivatives
    Patent number: 6506773
    Abstract: Pharmacologically active compounds are provided as well as pharmaceutical compositions and methods for treating cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration in a mammal.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: January 14, 2003
    Assignee: Darwin Discovery Ltd.
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Robert John Watson, John Fraser Keily, Andrew Douglas Baxter
  • Hydroxamic acid derivatives
    Patent number: 6455531
    Abstract: Compounds having therapeutic utility are of the formula wherein NB2 is heterocycloalkyl and R1 and R2 are each various substituents or a cyclic group.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: September 24, 2002
    Assignee: Darwin Discovery, Ltd.
    Inventors: David Alan Owen, Andrew Douglas Baxter, Robert John Watson, Duncan Robert Hannah, John Gary Montana
  • Hydroxamic acid derivatives
    Publication number: 20020037900
    Abstract: The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.
    Type: Application
    Filed: May 15, 2001
    Publication date: March 28, 2002
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Andrew Sharpe, Andrew Douglas Baxter
  • Hydroxamic and carboxylic acid derivatives
    Publication number: 20020022635
    Abstract: A phacologically actve compound of forula (1) 1
    Type: Application
    Filed: May 15, 2001
    Publication date: February 21, 2002
    Inventors: Duncan Robert Hannah, Hazel Joan Dyke, Robert John Watson, John Fraser Keily, Andrew Douglas Baxter